GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RetinalGenix Technologies RTGN · USD

Health Care · US listing · 🇺🇸 United States

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$2.4m

FY2020FY2025

Free cash flow

−$558,350

FY2020FY2025

Shareholders' equity

−$2.3m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Gross profit−$639,456−$703,930−$403,658−$370,523−$361,580—
Research and development$83,040$373,271$524,183$809,255$680,293$431,557
Operating income−$2.4m−$4.3m−$2.1m−$3.9m−$2.2m−$2.1m
Net income−$2.4m−$4.3m−$2.1m−$3.9m−$2.2m−$2.1m
Diluted earnings per share-0.13-0.23-0.12-0.23-0.15-0.15

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assets$21,041$14,946$156$294$4,947$61,075
Cash and short-term investments———$38——
Total liabilities$2.3m$1.5m$1.4m$1.1m$469,622$141,431
Debt———$49,000——
Shareholders' equity−$2.3m−$1.5m−$1.4m−$1.1m−$464,675−$80,356
Shares outstanding19m19m18m17m14m14m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−$558,350−$741,936−$451,661−$199,287−$1.2m−$1.4m
Capital spending———−$307−$307−$307
Free cash flow−$558,350−$741,936−$451,661−$199,594−$1.2m−$1.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Gross profit−$46,879−$96,774——−$218,354−$175,828——
Operating income−$303,442−$589,229−$622,059−$567,833−$648,348−$586,350−$866,067−$643,331
Net income−$307,397−$590,489−$623,127−$568,791−$649,418−$587,259−$867,027−$644,291
Diluted earnings per share-0.02-0.03-0.03-0.03-0.03-0.03-0.05-0.04
Total assets$32,215$5,805$21,041$7,001$8,388$11,931$14,946$88,854
Shareholders' equity−$2.6m−$2.6m−$2.3m−$2.2m−$2.0m−$1.7m−$1.5m−$1.9m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-14.7%3.1%—
Net income-14.7%3.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-24.7-2.2-3.8-1.9

Share price return

Finished calendar years

2025202420232022
Return533%13%3%400%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.